Korsana Biosciences, Inc. (KRSA)
31.65
+0.37
(+1.18%)
USD |
NASDAQ |
Nov 13, 16:00
31.58
-0.07
(-0.22%)
After-Hours: 19:59
Korsana Biosciences Total Assets (Quarterly) : 462.08M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 462.08M |
| June 30, 2026 | 6.93M |
| March 31, 2026 | 8.505M |
| December 31, 2025 | 9.985M |
| September 30, 2025 | 10.42M |
| June 30, 2025 | 9.37M |
| March 31, 2025 | 9.847M |
| December 31, 2024 | 9.575M |
| September 30, 2024 | 8.898M |
| June 30, 2024 | 10.06M |
| March 31, 2024 | 11.36M |
| December 31, 2023 | 13.37M |
| September 30, 2023 | 15.21M |
| June 30, 2023 | 10.10M |
| March 31, 2023 | 11.46M |
| December 31, 2022 | 18.08M |
| September 30, 2022 | 25.05M |
| June 30, 2022 | 35.21M |
| Date | Value |
|---|---|
| March 31, 2022 | 46.52M |
| December 31, 2021 | 59.33M |
| September 30, 2021 | 67.74M |
| June 30, 2021 | 75.73M |
| March 31, 2021 | 99.97M |
| December 31, 2020 | 115.38M |
| September 30, 2020 | 131.40M |
| June 30, 2020 | 128.04M |
| March 31, 2020 | 140.03M |
| December 31, 2019 | 186.48M |
| September 30, 2019 | 209.70M |
| June 30, 2019 | 235.50M |
| March 31, 2019 | 9.773M |
| December 31, 2018 | 7.401M |
| September 30, 2018 | 6.756M |
| June 30, 2018 | 5.724M |
| March 31, 2018 | |
| December 31, 2017 | 5.47M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Q32 Bio, Inc. | 297.20M |
| IRulya Therapeutics, Inc. | 106.47M |
| Climb Bio, Inc. | 236.56M |
| PepGen Inc. | 127.78M |
| Bridgebio Oncology Therapeutics, Inc. | 346.22M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 45.56M |
| Shareholders Equity (Quarterly) | 416.53M |
| Debt to Equity Ratio | 0.0031 |
| Current Ratio | 10.42 |
| Net Debt Paydown Yield | -0.02% |